ctDNA Assay in Patients With Resectable Pancreatic Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ctDNA Assay in Patients With Resectable Pancreatic Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm	Recruiting	Not stated	2026-03-05		NCT05052671

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Natera, Inc.	45
University of Oklahoma	146

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Stephenson Cancer Center- Tulsa	Tulsa	United States	2
University of Oklahoma	Oklahoma City	United States	4

Clinical trials